Heartflow Inc. Reports Preliminary Q2 2025 Revenue of $43.4 Million, Exceeds Initial Forecast; Gross Margin at 75.5%

Reuters
2025/09/10
Heartflow Inc. Reports Preliminary <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Revenue of $43.4 Million, Exceeds Initial Forecast; Gross Margin at 75.5%

Heartflow Inc. has released preliminary unaudited financial results for the three months ended June 30, 2025. The company reported revenue of approximately $43.4 million. The gross margin for this period is expected to be around 75.5%. Operating expenses are anticipated to be approximately $46.5 million. As of June 30, 2025, Heartflow's cash and cash equivalents stood at approximately $80.2 million. This figure does not include the net proceeds of about $333.0 million from the company's initial public offering completed on August 11, 2025. Additionally, during the three months ending September 30, 2025, the company plans to fully repay all amounts outstanding under its Credit Agreement and Guaranty with Hayfin Services LLP, which totaled $114.1 million as of June 30, 2025, plus accrued interest and related fees. Heartflow has also published an Investor Presentation on its website in connection with its participation at the Morgan Stanley 23rdAnnual Global Healthcare Conference.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001464521-25-000009), on September 10, 2025, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10